Taiko Pharmaceutical Co.,Ltd.

Taiko Pharmaceutical Co.,Ltd.verified

4574.T

Price:

$291

Market Cap:

$14.62B

Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed joint...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2009-03-18

Stock Exchange

JPX

Ticker

4574.T

The PE Ratio as of December 2025 (TTM) for Taiko Pharmaceutical Co.,Ltd. (4574.T) is -5.86

According to Taiko Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -5.86. This represents a change of -50.97% compared to the average of -11.95 of the last 4 quarters.

Taiko Pharmaceutical Co.,Ltd. (4574.T) Historical PE Ratio (quarterly & annually)

How has 4574.T PE Ratio performed in the past?

The mean historical PE Ratio of Taiko Pharmaceutical Co.,Ltd. over the last ten years is 14.44. The current -5.86 PE Ratio has changed -4157.50% with respect to the historical average. Over the past ten years (40 quarters), 4574.T's PE Ratio was at its highest in in the June 2018 quarter at 196.66. The PE Ratio was at its lowest in in the March 2015 quarter at -180.60.

Quarterly (TTM)
Annual

Average

14.44

Median

18.71

Minimum

-3.97

Maximum

27.03

Taiko Pharmaceutical Co.,Ltd. (4574.T) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Taiko Pharmaceutical Co.,Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 59.17%

Maximum Annual PE Ratio = 27.03

Minimum Annual Increase = -565.46%

Minimum Annual PE Ratio = -3.97

Quarterly (TTM)
Annual
YearPE RatioChange
202418.50-565.46%
2023-3.9713.21%
2022-3.51-6.07%
2021-3.74-120.68%
202018.08-33.12%
202027.0342.78%
201918.93-27.83%
201826.235.94%
201724.7611.93%
201622.1259.17%

Taiko Pharmaceutical Co.,Ltd. (4574.T) Average PE Ratio

How has 4574.T PE Ratio performed in the past?

The current PE Ratio of Taiko Pharmaceutical Co.,Ltd. (4574.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.67

5-year avg

5.07

10-year avg

14.44

Taiko Pharmaceutical Co.,Ltd. (4574.T) PE Ratio vs. Peers

How is 4574.T’s PE Ratio compared to its peers?

Taiko Pharmaceutical Co.,Ltd.’s PE Ratio is less than Fuso Pharmaceutical Industries,Ltd. (7.01), less than Colan Totte.Co.,Ltd. (10.51), less than Medical System Network Co., Ltd. (12.60), less than Solasia Pharma K.K. (-3.85), less than Daiken Medical Co., Ltd. (12.34), greater than MediciNova, Inc. (-6.48), greater than RaQualia Pharma Inc. (-49.21), less than Hoshi Iryo-Sanki Co., Ltd. (10.06), less than Techno Medica Co., Ltd. (16.82), greater than CellSeed Inc. (-9.03),

Build a custom stock screener for Taiko Pharmaceutical Co.,Ltd. (4574.T) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taiko Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taiko Pharmaceutical Co.,Ltd. (4574.T) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taiko Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Taiko Pharmaceutical Co.,Ltd.'s PE Ratio?

How is the PE Ratio calculated for Taiko Pharmaceutical Co.,Ltd. (4574.T)?

What is the highest PE Ratio for Taiko Pharmaceutical Co.,Ltd. (4574.T)?

What is the 3-year average PE Ratio for Taiko Pharmaceutical Co.,Ltd. (4574.T)?

What is the 5-year average PE Ratio for Taiko Pharmaceutical Co.,Ltd. (4574.T)?

How does the current PE Ratio for Taiko Pharmaceutical Co.,Ltd. (4574.T) compare to its historical average?